![Stacy Coen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stacy Coen
Corporate Officer/Principal at
IMMUNOGEN, INC.
Net worth: 435 $ as of 30/05/2026
Profile
Stacy A. Coen is Chief Business Officer & Senior Vice President at ImmunoGen, Inc. since 2020.
Current roles also include Member at Massachusetts Biotechnology Council, Trustee at Huntington's Disease Society of America, and Member at Alliance for Regenerative Medicine.
Former positions include Independent Director at FibroBiologics, Inc. from 2021 to 2026, Vice President at Genzyme Corp., and Vice President-Business Development at Editas Medicine, Inc. Education includes undergraduate studies at the University of Massachusetts and an MBA from the University of Virginia Darden School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
FIBROBIOLOGICS, INC. 0.01% | 23/04/2026 | 375 ( 0.01% ) | 435 $ | 30/05/2026 |
Stacy Coen active positions
| Companies | Position | Start |
|---|---|---|
| IMMUNOGEN, INC. | Corporate Officer/Principal | 02/06/2020 |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Corporate Officer/Principal | - |
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Corporate Officer/Principal | - |
Huntington's Disease Society of America | Director/Board Member | - |
Former positions of Stacy Coen
| Companies | Position | End |
|---|---|---|
| FIBROBIOLOGICS, INC. | Director/Board Member | 21/06/2026 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | - |
| EDITAS MEDICINE, INC. | Corporate Officer/Principal | - |
Training of Stacy Coen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
54
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Commercial Services |
Huntington's Disease Society of America | Commercial Services |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Editas Medicine, Inc.
 Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
University of Virginia Darden School of Business
 University of Virginia Darden School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
FibroBiologics, Inc.
 FibroBiologics, Inc. BiotechnologyHealth Technology Develops and commercializes fibroblast-based cell therapies | Health Technology |
- Stock Market
- Insiders
- Stacy Coen
